Volume 109, Issue 1 pp. 64-70

Lack of BLV and PTLV DNA sequences in the majority of patients with large granular lymphocyte leukaemia

Raisa N. Perzova

Raisa N. Perzova

Department of Medicine, SUNY Health Science Center, Syracuse, NY 13210,

Search for more papers by this author
Thomas P. Loughran JrSyamalima Dube

Syamalima Dube

Department of Medicine, SUNY Health Science Center, Syracuse, NY 13210,

Search for more papers by this author
Jorge Ferrer

Jorge Ferrer

Comparative Leukemia and Retrovirus Unit, New Bolton Center, University of Pennsylvania, Kennett Square, PA 19348, USA, and

Search for more papers by this author
Eduardo Esteban

Eduardo Esteban

Facultad de Ciencias Veterinarias, Universidad Nacional del Centro de la Provincia de Buenos Aires, Argentina

Search for more papers by this author
Bernard J. Poiesz

Bernard J. Poiesz

Department of Medicine, SUNY Health Science Center, Syracuse, NY 13210,

Search for more papers by this author
First published: 27 August 2008
Citations: 21
Dr Bernard J. Poiesz, Department of Medicine, SUNY Health Science Center at Syracuse, 750 E. Adams Street, Syracuse, NY 13210, USA. E-mail: [email protected].

Abstract

The primate T-cell lymphoma/leukaemia viruses (PTLV) and bovine leukaemia virus (BLV) comprise a unique genus of retroviruses, infection with which induces seroreactivity in the host against conserved epitopes in their p24 gag and gp21 env cognate proteins. Herein, we have confirmed this serocrossreactivity. Patients with large granular lymphocyte (LGL) leukaemia have frequent seroreactivity to the p24 and gp21 env proteins of human T-cell lymphoma/leukaemia virus I (HTLV-I), one of the species in the genus. However, only a small minority of patients are actually infected with prototypic HTLV-I or HTLV-II, another species within the group. In an attempt to determine whether LGL leukaemia might be associated with other members of the PTLV/BLV genus, we examined the peripheral blood mononuclear cell DNA of 22 HTLV p24 and/or gp21 seropositive LGL leukaemia patients via PCR using degenerate and specific primer pair/probe systems capable of detecting all known members of the PTLV/BLV genus. None of the samples was positive. These data indicate that although HTLV-II may be associated with some cases of LGL leukaemia most patients are not infected with a PTLV or BLV virus.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.